VONJO (pacritinib) capsules, for oral use Initial U.S. Approval: 2022
VONJO is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) Injection: 300 mg/30 mL (10 mg/mL) in a single-dose vial contact Alexion Pharmaceuticals, Inc.
If you have any questions about your illness, talk to your doctor
Source Details: Patient Information
Medicine Name: Vonjo
Generic Name: Pacritinib
Dosage Form & Strength: It comes as Capsules: 100 mg
Manufactured By: CTI BioPharma Corp
Access Patient Name Basis Treatment
IPN, New Delhi can facilitate patient to import of “VONJO (pacritinib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.